Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page. Removed the funding-lapse notice and the previous Revision: v3.4.1 entry.
    Difference
    0.5%
    Check dated 2026-02-11T06:16:09.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a government funding notice about site status. Updated the revision to v3.4.1, replacing the previous v3.4.0 note.
    Difference
    0.5%
    Check dated 2026-02-04T04:41:07.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Results status changed from 'No Results Posted' to 'Results Submitted'; the label 'No Results Posted' was removed. The page also adds 'Show glossary' and QC-related updates such as 'Last Update Submitted that Met QC Criteria' and Revision: v3.4.0.
    Difference
    0.3%
    Check dated 2026-01-28T02:59:36.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T01:36:28.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Footer now shows 'Revision: v3.3.3'; 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T09:31:28.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Footer Revision notice updated from v3.3.1 to v3.3.2. This is a minor UI/metadata change and does not affect any study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2025-12-01T17:13:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.